Category

• Business3
• Pipeline1

Organizations

• Bausch + Lomb64
• Eyes On Eyecare42
• Alcon, Inc.41
• American Optometric Association34
• Harrow26
• Glaukos25
• Regeneron21
• Aldeyra Therapeutics20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Eye Drops2
• FDA1
• Nyxol1
• Dry Eye Disease1
• Pharmaceuticals1
• Presbyopia1

• Organizations: Famy Life Sciences✕

Clear all

Business

Viatris officially acquires Oyster Point Pharma, Famy Life Sciences

The company now owns the rights to Tyrvaya as part of its newly established Viatris Eye Care Division.

Pipeline

Ocuphire submits NDA to FDA for Nyxol

Ocuphire is seeking an NDA for Nyxol for the reversal of pharmacologically-induced mydriasis.

Business

New exclusive license agreement gives Ocuphire rights to develop, commercialize Nyxol

The preservative-free eye drop is getting new ownership.

Business

Viatris seals the deal on two ophthalmic acquisitions

Viatris just announced it will acquire Oyster Point Pharma and Famy Life Sciences.